Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014


PharmAccess Leaders Forum

19 May 2014 - 21 May 2014 - Paris, France



Bookmark and Share


NextLevel Pharma’s PharmAccess Leaders Forum is quickly becoming THE “must attend” event for senior representatives of the market access community in Europe. With over 30 senior-level speakers from Payers, HTAs, Hospitals, stakeholder groups, and not to mention the pharmaceutical industry, more than 100 participants will attend. Attendees will achieve the most relevant learning, benchmarking and networking experience available for senior executives who are involved in patient access, health economics, outcomes, pricing and reimbursement. 3 EVENTS IN ONE: 1. Innovative Pricing & Reimbursement Agreements 2. Achieving Market Access for High-Value Oncology Therapeutics 3. Best Practices in Economic Modeling to Demonstrate Superior Outcomes & Value This year’s “Spring Edition” in Paris, will focus the audience on the necessary steps to achieving rapid market access, through enhanced value-demonstration, whilst delivering as much certainty as possible for payers, as well as delivering the patient with the most innovative & beneficial products possible. Request agenda at http://springpharmaccess2014.nextlevelpharma.com/request-agenda or contact me directly for more information. We look forward to meeting you in Paris!

Further information
Scientific News
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Recruitment of First Patient in Clinical Study
Company has announced recruitment of first patient in clinical study assessing Visco-ease with Beatson Cancer Centre for the treatment of RIX.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!